Pfizer says it will charge other developed countries on par with US for vaccine deals
- The US government agreed to pay nearly $2 billion to buy enough of a COVID-19 vaccine being developed by Pfizer and BioNTech SE.
- All the countries that are developed right now will not receive a lower price for the same volume commitment than the US.